Uterine fibroids affect up to 80% [1] of women of reproductive age, yet medical experts said the condition remains widely misunderstood.
This lack of awareness often leads to delayed diagnosis and inadequate treatment options. Because these growths disproportionately affect women of color, the gap in understanding can exacerbate existing healthcare disparities in the U.S.
Fibroids are the most common [2] non-cancerous growth in the female reproductive system. Despite their prevalence, many patients encounter misconceptions regarding who is susceptible to the condition and how it should be managed. Dr. Soyini Hawkins and Sateria Venable said these challenges during a PBS NewsHour segment moderated by William Brangham.
The discussion focused on the need for better patient education and a broader range of treatment options. Experts said that the prevalence of fibroids in women of color requires a more nuanced approach to care. Some patients have historically faced barriers to accessing minimally invasive procedures, such as uterine fibroid embolization, which can offer an alternative to more invasive surgeries.
Misconceptions about the condition persist even as medical data confirms its high frequency among women. The lack of public discourse often leaves patients feeling isolated or confused about their symptoms. By increasing awareness, health providers aim to ensure that women receive timely and appropriate interventions based on their specific medical needs.
Addressing these gaps involves both clinician education and patient advocacy. When women are informed about the nature of fibroids, they are better equipped to navigate the healthcare system and demand effective treatments. The goal is to move toward a standard of care where the high prevalence of these growths is met with proportional medical attention and understanding.
“Uterine fibroids affect up to 80% of women of reproductive age”
The persistence of misconceptions about uterine fibroids despite their high prevalence suggests a systemic failure in public health communication. Because the condition heavily impacts women of color, this lack of awareness is not merely a medical oversight but a public health issue that can lead to poorer outcomes for marginalized populations.
